alexa Case Series: Deep Brain Stimulation in Patients with FX
ISSN: 2168-975X

Brain Disorders & Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Case Series: Deep Brain Stimulation in Patients with FXTAS

Randi J Hagerman1,2, Jamie S Pak3, Melina Ortigas1, John Olichney4, Robert Frysinger5, Madeline Harrison6, Edmund Cornman7, Danuta Z. Loesch8, Richard G Bittar9, Richard Peppard10, Lin Zhang4* and Kiarash Shahlaie11
1Department of Pediatrics, M.I.N.D. Institute, School of Medicine, University of California, Davis, Sacramento, CA, USA
2Department of Pediatrics, School of Medicine, University of California, Davis, Sacramento, CA, USA
3Mount Sinai School of Medicine, Department of Dermatology, Mount Sinai Medical Center, New York, NY, USA
4Department of Neurology, School of Medicine, University of California, Davis, Sacramento, CA, USA
5Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville, VA, USA
6Department of Neurology, University of Virginia School of Medicine, Charlottesville, VA, USA
7Department of Sleep Medicine and Neurology, Sleep Disorders Center of Virginia, Midlothian, VA, USA
8Department of Psychology, School of Psychological Science, La Trobe University, Melbourne, VIC, Australia
9Department of Neurological Surgery, Precision Neurosurgery, Melbourne, Australia
10Department of Neurology, St. Vincent’s Hospital, Carlton, VIC, Australia
11Department of Neurological Surgery, School of Medicine, University of California, Davis, Sacramento, CA, USA
Corresponding Author : Lin Zhang, MD, PhD
Lawrence J. Ellison Ambulatory Care Center
4860 Y St, Suite 0100, Sacramento, CA, USA, 95817
Tel: (916) 734-3588
E-mail: [email protected]
Received June 05, 2012; Accepted August 03, 2012; Published August 05, 2012
Citation: Hagerman RJ, Pak JS, Ortigas M, Olichney J, Frysinger R, et al. (2012) Case Series: Deep Brain Stimulation in Patients with FXTAS. Brain Disord Ther 1:104. doi:10.4172/2168-975X.1000104
Copyright: © 2012 Hagerman RJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 

Abstract

Objective: We describe 3 carriers of the FMR1 premutation with the Fragile X-associated Tremor Ataxia Syndrome (FXTAS) whose tremor was significantly improved by bilateral Deep Brain Stimulation (DBS) to Ventral Intermediate nucleus (Vim) of the thalamus.
 
Background: FXTAS is a recently described neurodegenerative disorder caused by CGG expansions of the FMR1 gene within the premutation range (55 to 200 CGG repeats). Individuals with FXTAS typically develop an intention tremor followed by gait ataxia within two years. Vim DBS has been shown to effectively treat tremor in a variety of disorders, including Parkinson’s disease and essential tremor.
 
Design/Methods/Results: Three men ages 62, 59 and 70 with FXTAS were treated surgically with bilateral Vim DBS. All patients experienced a significantly beneficial effect on tremor. Ataxia improved in case 1 and temporarily in case 2, but worsened in case 3. All patients experienced mild worsening of dysarthria, although the patients and their families unanimously felt there was a worthwhile benefit overall.
 
Conclusions: These cases provided first hand evidence that bilateral Vim DBS effectively manages tremor in selected patients with FXTAS. DBS may prove to be a viable therapeutic option for treating tremor and/or ataxia with or without other medical therapeutics in patients with FXTAS.

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]line.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords